This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (15)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

SIDNEY LERMAN, M.D.; BURTON M. POGELL, Ph.D.; WOLFGANG LIEB, M.D.

AMA Arch Ophthalmol. 1957;57(3):354-360.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The increase in the life expectancy of diabetics which has occurred in the post-insulin era, and which has been further augmented by the general advances in the understanding and treatment of metabolic disorders, has led to an increase in the degenerative complications of diabetes. Such is apparently the case with diabetic retinopathy, a complication which intimately concerns the ophthalmologist. Friedenwald² and Vogelius,³ among others, have reported a marked increase in the incidence of retinopathy in the patients they studied, and, although there is still a good deal of controversy regarding the relationship of retinal disease to the degree of control of blood sugar, it is now generally accepted that the most important factor is the duration of the diabetes. The histopathological picture of diabetic retinal disease has been well defined by the excellent studies carried out by Ballantyne and Loewenstein,⁴ Ashton,⁵ and Friedenwald,^2,6 and the . . . [Full Text PDF of this Article]

Author Affiliations
Baltimore

From the Wilmer Ophthalmological Institute of The Johns Hopkins University and Hospital. J. B. Collip Foundation Research Fellow, McGill University and Department of Ophthalmology, Montreal General Hospital (Dr. Lerman).

Footnotes
Received for publication Oct. 4, 1956.

A preliminary report was presented at the Eastern Section Meeting of the Association for Research in Ophthalmology, New York, April 28, 1956.1

This investigation was supported in part by a research grant (B-141) from the National Institute of Neurological Diseases and Blindness, National Institutes of Health, United States Public Health Service.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?